Huang and associates validated this hypothesis by demonstrating that the loss of the Farnesoid X Receptor (FXR) leads to p53 acetylation in a CREB Binding Protein (CBP)-dependent manner, consequently initiating ferroptosis and constraining breast cancer proliferation and metastasis [79]. The gene discussed is NR1H4; the disease is breast cancer.